PROBE-FFR: Relationship Between Coronary Angiography Findings and Fractional Flow Reserve After Balloon Angioplasty

Sponsor
Seoul National University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05716997
Collaborator
Ewha Womans University Mokdong Hospital (Other)
100
2
24.4
50
2.1

Study Details

Study Description

Brief Summary

The goal of this prospective observational study is to learn about in patients who need percutaneous coronary intervention for coronary artery disease. The main questions it aims to answer are:

  • Fractional flow reserve according to coronary angiography findings after coronary artery balloon angioplasty

  • Differences in fractional blood flow reserve before and after lesions between coronary balloon angioplasty using a scoring balloon and a regular balloon Participants will voluntarily consent to the study after being fully informed about the study and given ample opportunity to ask questions.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    A PRospective Observational Study on the Relationship BEtween Coronary Angiography Findings and Fractional Flow Reserve After Balloon Angioplasty: PROBE-FFR
    Actual Study Start Date :
    Dec 20, 2022
    Anticipated Primary Completion Date :
    Dec 31, 2023
    Anticipated Study Completion Date :
    Dec 31, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Differences in fractional flow reserve (FFR) according to angiographic findings after coronary artery balloon angioplasty [15 minutes]

      Coronary angiographic findings and fractional flow within 15 minutes after coronary balloon angioplasty are collected and analyzed.

    Secondary Outcome Measures

    1. Comparison of differences in fractional flow reserve (FFR) before and after lesions between coronary balloon angioplasty using a scoring balloon and a regular balloon [1 year]

      Determine whether a scoring balloon or a general balloon was used during balloon angioplasty, and analyze whether there is a difference in FFR depending on the balloon used.

    2. 1-year outcome [1 year]

      Relationship between major cardiac events within 1 year according to changes in pre- and post-lesional fractional flow reserve (FFR), steady-state pressure ratio, and quantitative flow analysis (QFR) values before and after coronary artery balloon angioplasty

    3. Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific minimum lumen area [1 year]

      Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific minimum lumen area (mm2)

    4. Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific plaque burden [1 year]

      Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific plaque burden (plaque burden = plaque cross-sectional area (CSA, mm2)+ media CSA / external elastic membrane CSA)

    5. Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific positive remodeling [1 year]

      Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific positive remodeling (remodeling ratio > 1.05). remodeling ratio (RR) = external elastic membrane (EEM) area lesion/EEM area proximal reference

    6. Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific attenuated plaque [1 year]

      Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific attenuated plaque Attenuated Plaque: Plaque seen in intravascular ultrasound with acoustic shadowing behind large, echolucent acute culprit lesion sites, in the absence of bright calcium.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 120 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Patients with clinically stable coronary artery disease

    • Patients undergoing balloon angioplasty as an interventional procedure (FFR-guided PCI) using coronary artery fractional blood flow reserve for de novo lesions with a standard vessel diameter of 2.25 mm or more under percutaneous coronary angiography (hereafter referred to as coronary angiography)

    (Note) If there are other lesions in the proximal area and the FFR of the distal lesion is collected, it is included in the selection target regardless of whether or not the proximal lesion was operated on.

    Exclusion Criteria:
    • Target lesion with stenosis of less than 50% or greater than 90% of the internal diameter

    • Procedure for restenosis within the stent

    • Pre-dilation performed on the target lesion before the coronary artery fractional blood flow reserve test

    • Prior coronary artery bypass surgery

    • Clinically unstable or ST-segment elevation myocardial infarction

    • Myocardial infarction in the region supplied by the target vessel

    • Target vessel is a blood vessel that supplies collateral circulation for occlusion of other blood vessels (not applicable when the need for collateral circulation has been resolved due to the opening of another vessel occlusion)

    • Left ventricular ejection fraction (EF) less than 30%

    • Most recently measured eGFR is less than 30 right before the procedure

    • Accompanying primary valve disease requiring treatment

    • Accompanying primary heart disease such as dilated cardiomyopathy, hypertrophic cardiomyopathy, or restrictive cardiomyopathy

    • Congenital heart disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ewha Womans University Mokdong Hospital Seoul Korea, Republic of
    2 Seou National University Hospital Seoul Korea, Republic of

    Sponsors and Collaborators

    • Seoul National University Hospital
    • Ewha Womans University Mokdong Hospital

    Investigators

    • Study Chair: Bon-Kwon Koo, MD, Seoul National University Hospital
    • Study Director: Bon-Kwon Koo, MD, Seoul National University Hospital
    • Principal Investigator: Bon-Kwon Koo, MD, Seoul National University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Bon-Kwon Koo, Professor, Seoul National University Hospital
    ClinicalTrials.gov Identifier:
    NCT05716997
    Other Study ID Numbers:
    • PROBE-FFR
    First Posted:
    Feb 8, 2023
    Last Update Posted:
    Feb 8, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Bon-Kwon Koo, Professor, Seoul National University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 8, 2023